{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:25:50Z","timestamp":1793244350977,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10405-0","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T02:09:05Z","timestamp":1735783745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between latent toxoplasmosis and bipolar disorder: a case-control seroprevalence study"],"prefix":"10.1186","volume":"25","author":[{"given":"Abdol Sattar","family":"Pagheh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele Sadat","family":"Talebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooran","family":"Nayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisa","family":"Nazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"10405_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fvets.2020.00461","volume":"7","author":"TM Mikaeili-Galeh","year":"2020","unstructured":"Mikaeili-Galeh TM, Sarvi S, Montazeri M, Moosazadeh M, Nakhaei M, Shariatzadeh SA, Daryani A. Global status of Toxoplasma gondii seroprevalence in rodents: a systematic review and meta-analysis. Front Vet Sci. 2020;7:461. https:\/\/doi.org\/10.3389\/fvets.2020.00461.","journal-title":"Front Vet Sci"},{"issue":"1","key":"10405_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10393-022-01575-x","volume":"19","author":"B Hajimohammadi","year":"2022","unstructured":"Hajimohammadi B, Ahmadian S, Firoozi Z, Askari M, Mohammadi M, Eslami G, Askari V, Loni E, Barzegar-Bafrouei R, Boozhmehrani MJ. A Meta-analysis of the prevalence of toxoplasmosis in livestock and poultry worldwide. EcoHealth. 2022;19(1):55\u201374. https:\/\/doi.org\/10.1007\/s10393-022-01575-x.","journal-title":"EcoHealth"},{"issue":"8","key":"10405_CR3","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.4103\/jfmpc.jfmpc_753_20","volume":"9","author":"V Rahmanian","year":"2020","unstructured":"Rahmanian V, Rahmanian K, Jahromi AS, Bokaie S. Seroprevalence of toxoplasma gondii infection: an umbrella review of updated systematic reviews and meta-analyses. J Family Med Prim Care. 2020;9(8):3848. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_753_20.","journal-title":"J Family Med Prim Care"},{"issue":"12","key":"10405_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1017\/S0031182021001116","volume":"148","author":"SA Shariatzadeh","year":"2021","unstructured":"Shariatzadeh SA, Sarvi S, Hosseini SA, Sharif M, Gholami S, Pagheh AS, Montazeri F, Nayeri T, Nakhaei M, Galeh TM. The global seroprevalence of Toxoplasma gondii infection in bovines: a systematic review and meta-analysis. Parasitology. 2021;148(12):1417\u201333. https:\/\/doi.org\/10.1017\/S0031182021001116.","journal-title":"Parasitology"},{"key":"10405_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11686-020-00333-9","volume":"66","author":"N Maspi","year":"2021","unstructured":"Maspi N, Nayeri T, Moosazadeh M, Sarvi S, Sharif M, Daryani A. Global seroprevalence of Toxoplasma Gondii in Camelidae: a systematic review and meta-analysis. Acta Parasitol. 2021;66:733\u201344. https:\/\/doi.org\/10.1007\/s11686-020-00333-9.","journal-title":"Acta Parasitol"},{"issue":"6","key":"10405_CR6","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1111\/tbed.14753","volume":"69","author":"M Ahaduzzaman","year":"2022","unstructured":"Ahaduzzaman M, Hasan T. Seroprevalence of Toxoplasma gondii infection in sheep and goats from different geographical regions of the world: systematic review and meta-analysis. Transbound Emerg Dis. 2022;69(6):3790\u2013822. https:\/\/doi.org\/10.1111\/tbed.14753.","journal-title":"Transbound Emerg Dis"},{"issue":"8","key":"10405_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1017\/S0031182021000433","volume":"148","author":"T Nayeri","year":"2021","unstructured":"Nayeri T, Sarvi S, Daryani A. Toxoplasma Gondii in mollusks and cold-blooded animals: a systematic review. Parasitology. 2021;148(8):895\u2013903. https:\/\/doi.org\/10.1017\/S0031182021000433.","journal-title":"Parasitology"},{"key":"10405_CR8","doi-asserted-by":"publisher","first-page":"104578","DOI":"10.1016\/j.micpath.2020.104578","volume":"149","author":"H Pazoki","year":"2020","unstructured":"Pazoki H, Ziaee M, Anvari D, Rezaei F, Ahmadpour E, Haghparast-Kenari B, Saljoghi F, Biderouni FT, Barac A, Pagheh AS. Toxoplasma Gondii infection as a potential risk for chronic liver diseases: a systematic review and meta-analysis. Microb Pathog. 2020;149:104578. https:\/\/doi.org\/10.1016\/j.micpath.2020.104578.","journal-title":"Microb Pathog"},{"issue":"1\u20132","key":"10405_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vetpar.2004.09.005","volume":"126","author":"J Dubey","year":"2004","unstructured":"Dubey J. Toxoplasmosis- a waterborne zoonosis. Vet Parasitol. 2004;126(1\u20132):57\u201372. https:\/\/doi.org\/10.1016\/j.vetpar.2004.09.005.","journal-title":"Vet Parasitol"},{"key":"10405_CR10","doi-asserted-by":"publisher","first-page":"105920","DOI":"10.1016\/j.biocel.2021.105920","volume":"132","author":"AS Pagheh","year":"2021","unstructured":"Pagheh AS, Daryani A, Alizadeh P, Hassannia H, Oliveira SMR, Kazemi T, Rezaei F, de Lourdes Pereira M, Ahmadpour E. Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice. Int J Biochem Cell Biol. 2021;132:105920. https:\/\/doi.org\/10.1016\/j.biocel.2021.105920.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10405_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0169-4758(98)01377-5","volume":"15","author":"F Roberts","year":"1999","unstructured":"Roberts F, McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today. 1999;15(2):51\u20137. https:\/\/doi.org\/10.1016\/s0169-4758(98)01377-5.","journal-title":"Parasitol Today"},{"issue":"11","key":"10405_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","volume":"38","author":"J Dubey","year":"2008","unstructured":"Dubey J, Jones J. Toxoplasma Gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):1257\u201378. https:\/\/doi.org\/10.1016\/j.ijpara.2008.03.007.","journal-title":"Int J Parasitol"},{"key":"10405_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jad.2016.11.016","volume":"209","author":"JLVM de Barros","year":"2017","unstructured":"de Barros JLVM, Barbosa IG, Salem H, Rocha NP, Kummer A, Okusaga OO, Soares JC, Teixeira AL. Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J Affect Disord. 2017;209:59\u201365. https:\/\/doi.org\/10.1016\/j.jad.2016.11.016.","journal-title":"J Affect Disord"},{"key":"10405_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.08.003","volume":"299","author":"L Ene","year":"2016","unstructured":"Ene L, Marcotte T, Umlauf A, Grancea C, Temereanca A, Bharti A, Achim C, Letendre S, Ruta S. Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. J Neuroimmunol. 2016;299:1\u20137. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.003.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10405_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/schbul\/sbm021","volume":"33","author":"Z Cetinkaya","year":"2007","unstructured":"Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample. Schizophr Bull. 2007;33(3):789\u201391. https:\/\/doi.org\/10.1093\/schbul\/sbm021.","journal-title":"Schizophr Bull"},{"issue":"2","key":"10405_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000180267","volume":"16","author":"S Henriquez","year":"2009","unstructured":"Henriquez S, Brett R, Alexander J, Pratt J, Roberts C. Neuropsychiatric disease and Toxoplasma Gondii infection. Neuroimmunomodulation. 2009;16(2):122\u201333. https:\/\/doi.org\/10.1159\/000180267.","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10405_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1242\/jeb.074153","volume":"216","author":"GA McConkey","year":"2013","unstructured":"McConkey GA, Martin HL, Bristow GC, Webster JP. Toxoplasma Gondii infection and behaviour\u2013location, location. Location? J Exp Biol. 2013;216(1):113\u20139. https:\/\/doi.org\/10.1242\/jeb.074153.","journal-title":"Location? J Exp Biol"},{"issue":"1","key":"10405_CR18","first-page":"117","volume":"12","author":"E Abdollahian","year":"2017","unstructured":"Abdollahian E, Shafiei R, Mokhber N, Kalantar K, Fata A. Seroepidemiological study of Toxoplasma Gondii infection among psychiatric patients in Mashhad, Northeast of Iran. Iran J Parasitol. 2017;12(1):117.","journal-title":"Iran J Parasitol"},{"issue":"3","key":"10405_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/JMAU.JMAU_22_18","volume":"6","author":"MA Afifi","year":"2018","unstructured":"Afifi MA, Jiman-Fatani AA, Al-Rabia MW, Al-Hussainy NH, El Saadany S, Mayah W. More than an association: latent toxoplasmosis might provoke a local oxidative stress that triggers the development of bipolar disorder. J Microsc Ultrastruct. 2018;6(3):139. https:\/\/doi.org\/10.4103\/JMAU.JMAU_22_18.","journal-title":"J Microsc Ultrastruct"},{"issue":"3","key":"10405_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241\u201351.","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10405_CR21","doi-asserted-by":"publisher","first-page":"e23866","DOI":"10.1371\/journal.pone.0023866","volume":"6","author":"E Prandovszky","year":"2011","unstructured":"Prandovszky E, Gaskell E, Martin H, Dubey J, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma Gondii increases dopamine metabolism. PLoS ONE. 2011;6(9):e23866. https:\/\/doi.org\/10.1371\/journal.pone.0023866.","journal-title":"PLoS ONE"},{"issue":"3","key":"10405_CR22","doi-asserted-by":"publisher","first-page":"e4801","DOI":"10.1371\/journal.pone.0004801","volume":"4","author":"EA Gaskell","year":"2009","unstructured":"Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA. A unique dual activity amino acid hydroxylase in Toxoplasma Gondii. PLoS ONE. 2009;4(3):e4801. https:\/\/doi.org\/10.1371\/journal.pone.0004801.","journal-title":"PLoS ONE"},{"issue":"2","key":"10405_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/00034983.1985.11811902","volume":"79","author":"H Stibbs","year":"1985","unstructured":"Stibbs H. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma Gondii infected mice. Ann Trop Med Parasitol. 1985;79(2):153\u20137. https:\/\/doi.org\/10.1080\/00034983.1985.11811902.","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"10405_CR24","doi-asserted-by":"publisher","first-page":"e1004935","DOI":"10.1371\/journal.ppat.1004935","volume":"11","author":"A Vyas","year":"2015","unstructured":"Vyas A. Mechanisms of host behavioral change in Toxoplasma Gondii rodent association. PLoS Pathog. 2015;11(7):e1004935. https:\/\/doi.org\/10.1371\/journal.ppat.1004935.","journal-title":"PLoS Pathog"},{"issue":"1","key":"10405_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/pathogens6010003","volume":"6","author":"C Del Grande","year":"2017","unstructured":"Del Grande C, Galli L, Schiavi E, Dell\u2019Osso L, Bruschi F. Is Toxoplasma gondii a trigger of bipolar disorder? Pathogens. 2017;6(1):3. https:\/\/doi.org\/10.3390\/pathogens6010003.","journal-title":"Pathogens"},{"issue":"1589","key":"10405_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1098\/rspb.2005.3413","volume":"273","author":"J Webster","year":"2006","unstructured":"Webster J, Lamberton P, Donnelly C, Torrey E. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma Gondii\u2019s ability to alter host behaviour. Proc Biol Sci. 2006;273(1589):1023\u201330. https:\/\/doi.org\/10.1098\/rspb.2005.3413.","journal-title":"Proc Biol Sci"},{"issue":"3","key":"10405_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0920-9964(02)00357-2","volume":"62","author":"L Jones-Brando","year":"2003","unstructured":"Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma Gondii. Schizophr Res. 2003;62(3):237\u201344. https:\/\/doi.org\/10.1016\/s0920-9964(02)00357-2.","journal-title":"Schizophr Res"},{"issue":"3","key":"10405_CR28","first-page":"211","volume":"49","author":"Y Tedla","year":"2011","unstructured":"Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A. Serum antibodies to Toxoplasma Gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J. 2011;49(3):211\u201320.","journal-title":"Ethiop Med J"},{"issue":"2\u20133","key":"10405_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jad.2012.11.034","volume":"148","author":"N Hamdani","year":"2013","unstructured":"Hamdani N, Daban-Huard C, Lajnef M, Richard J-R, Delavest M, Godin O, Le Guen E, Vederine F-E, L\u00e9pine J-P, Jamain S. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013;148(2\u20133):444\u20138. https:\/\/doi.org\/10.1016\/j.jad.2012.11.034.","journal-title":"J Affect Disord"},{"issue":"7\u20138","key":"10405_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1399-5618.2011.00962.x","volume":"13","author":"PB Mortensen","year":"2011","unstructured":"Mortensen PB, Pedersen CB, McGrath JJ, Hougaard DM, N\u00f8rgaard-Petersen B, Mors O, B\u00f8rglum AD, Yolken RH. Neonatal antibodies to infectious agents and risk of bipolar disorder: a population\u2010based case\u2013control study. Bipolar Disord. 2011;13(7\u20138):624\u20139. https:\/\/doi.org\/10.1111\/j.1399-5618.2011.00962.x.","journal-title":"Bipolar Disord"},{"issue":"3","key":"10405_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/schbul\/sbm009","volume":"33","author":"PB Mortensen","year":"2007","unstructured":"Mortensen PB, N\u00f8rgaard-Pedersen B, Waltoft BL, S\u00f8rensen TL, Hougaard D, Yolken RH. Early infections of Toxoplasma Gondii and the later development of schizophrenia. Schizophr Bull. 2007;33(3):741\u20134. https:\/\/doi.org\/10.1093\/schbul\/sbm009.","journal-title":"Schizophr Bull"},{"issue":"3","key":"10405_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.12423","volume":"132","author":"A Sutterland","year":"2015","unstructured":"Sutterland A, Fond G, Kuin A, Koeter M, Lutter R, Van Gool T, Yolken R, Szoke A, Leboyer M, De Haan L. Beyond the association. T oxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 2015;132(3):161\u201379.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10405_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/schbul\/sbl050","volume":"33","author":"EF Torrey","year":"2007","unstructured":"Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma Gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2007;33(3):729\u201336. https:\/\/doi.org\/10.1093\/schbul\/sbl050.","journal-title":"Schizophr Bull"},{"issue":"4","key":"10405_CR34","doi-asserted-by":"publisher","first-page":"e0007306","DOI":"10.1371\/journal.pntd.0007306","volume":"13","author":"T Nayeri Chegeni","year":"2019","unstructured":"Nayeri Chegeni T, Sarvi S, Amouei A, Moosazadeh M, Hosseininejad Z, Aghayan SA, Daryani A. Relationship between toxoplasmosis and obsessive compulsive disorder: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(4):e0007306. https:\/\/doi.org\/10.1371\/journal.pntd.0007306.","journal-title":"PLoS Negl Trop Dis"},{"key":"10405_CR35","doi-asserted-by":"publisher","first-page":"103751","DOI":"10.1016\/j.micpath.2019.103751","volume":"137","author":"T Nayeri Chegeni","year":"2019","unstructured":"Nayeri Chegeni T, Sarvi S, Moosazadeh M, Sharif M, Aghayan SA, Amouei A, Hosseininejad Z, Daryani A. Is Toxoplasma gondii a potential risk factor for Alzheimer\u2019s disease? A systematic review and meta-analysis. Microb Pathog. 2019;137:103751. https:\/\/doi.org\/10.1016\/j.micpath.2019.103751.","journal-title":"Microb Pathog"},{"key":"10405_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.actatropica.2019.05.015","volume":"196","author":"M Bayani","year":"2019","unstructured":"Bayani M, Riahi SM, Bazrafshan N, Ray Gamble H, Rostami A. Toxoplasma Gondii infection and risk of Parkinson and Alzheimer diseases: a systematic review and meta-analysis on observational studies. Acta Trop. 2019;196:165\u201371. https:\/\/doi.org\/10.1016\/j.actatropica.2019.05.015.","journal-title":"Acta Trop"},{"issue":"8","key":"10405_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/trstmh\/trz025","volume":"113","author":"M Sadeghi","year":"2019","unstructured":"Sadeghi M, Riahi SM, Mohammadi M, Saber V, Aghamolaie S, Moghaddam SA, Aghaei S, Javanian M, Gamble HR, Rostami A. An updated meta-analysis of the association between Toxoplasma Gondii infection and risk of epilepsy. Trans R Soc Trop Med Hyg. 2019;113(8):453\u201362. https:\/\/doi.org\/10.1093\/trstmh\/trz025.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10405_CR38","doi-asserted-by":"publisher","first-page":"e0003525","DOI":"10.1371\/journal.pntd.0003525","volume":"9","author":"EB Ngoungou","year":"2015","unstructured":"Ngoungou EB, Bhalla D, Nzoghe A, Darde ML, Preux PM. Toxoplasmosis and epilepsy-systematic review and meta analysis. PLoS Negl Trop Dis. 2015;9(2):e0003525. https:\/\/doi.org\/10.1371\/journal.pntd.0003525.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10405_CR39","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1017\/S0033291719000813","volume":"49","author":"AL Sutterland","year":"2019","unstructured":"Sutterland AL, Kuin A, Kuiper B, van Gool T, Leboyer M, Fond G, de Haan L. Driving us mad: the association of Toxoplasma Gondii with suicide attempts and traffic accidents - a systematic review and meta-analysis. Psychol Med. 2019;49(10):1608\u201323. https:\/\/doi.org\/10.1017\/S0033291719000813.","journal-title":"Psychol Med"},{"key":"10405_CR40","doi-asserted-by":"publisher","first-page":"104434","DOI":"10.1016\/j.micpath.2020.104434","volume":"147","author":"T Nayeri","year":"2020","unstructured":"Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Sharif M, Amouei A, Daryani A. Relationship between toxoplasmosis and autism: a systematic review and meta-analysis. Microb Pathog. 2020;147:104434. https:\/\/doi.org\/10.1016\/j.micpath.2020.104434.","journal-title":"Microb Pathog"},{"issue":"4","key":"10405_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/1871526520666200617135851","volume":"21","author":"TSS Nayeri","year":"2021","unstructured":"Nayeri TSS, Moosazadeh M, Hosseininejad Z, Amouei A, Daryani A. Association between Toxoplasma Gondii infection and headache: a systematic review and meta-analysis. Infect Disord Drug Targets. 2021;21(4):643\u201350. https:\/\/doi.org\/10.2174\/1871526520666200617135851.","journal-title":"Infect Disord Drug Targets"},{"issue":"6","key":"10405_CR42","doi-asserted-by":"publisher","first-page":"e0218524","DOI":"10.1371\/journal.pone.0218524","volume":"14","author":"T Nayeri Chegeni","year":"2019","unstructured":"Nayeri Chegeni T, Sharif M, Sarvi S, Moosazadeh M, Montazeri M, Aghayan SA, Balalami NJ, Gholami S, Hosseininejad Z, Saberi R, et al. Is there any association between Toxoplasma gondii infection and depression? A systematic review and meta-analysis. PLoS ONE. 2019;14(6):e0218524. https:\/\/doi.org\/10.1371\/journal.pone.0218524.","journal-title":"PLoS ONE"},{"key":"10405_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/20477724.2020.1738153","volume":"114","author":"T Nayeri","year":"2020","unstructured":"Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Amouei A, Daryani A. Toxoplasma Gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis. Pathog Glob Health. 2020;114:1\u201310. https:\/\/doi.org\/10.1080\/20477724.2020.1738153.","journal-title":"Pathog Glob Health"},{"key":"10405_CR44","first-page":"7","volume":"3","author":"SS Mahmoud","year":"2009","unstructured":"Mahmoud SS, Hasan MS. Seroprevalence of toxoplasmosis among schizophrenic patients. Yemeni J Med Sci. 2009;3:7\u20137.","journal-title":"Yemeni J Med Sci"},{"key":"10405_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpsychires.2022.07.013","volume":"153","author":"G Cossu","year":"2022","unstructured":"Cossu G, Preti A, Gyppaz D, Gureje O, Carta MG. Association between toxoplasmosis and bipolar disorder: a systematic review and meta-analysis. J Psychiatr Res. 2022;153:284\u201391. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.07.013.","journal-title":"J Psychiatr Res"},{"key":"10405_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.actatropica.2019.02.001","volume":"192","author":"X Chen","year":"2019","unstructured":"Chen X, Chen B, Hou X, Zheng C, Yang X, Ke J, Hu X, Tan F. Association between Toxoplasma Gondii infection and psychiatric disorders in Zhejiang, Southeastern China. Acta Trop. 2019;192:82\u20136. https:\/\/doi.org\/10.1016\/j.actatropica.2019.02.001.","journal-title":"Acta Trop"},{"issue":"1","key":"10405_CR47","doi-asserted-by":"publisher","first-page":"15092","DOI":"10.1038\/s41598-022-16420-y","volume":"12","author":"T Liu","year":"2022","unstructured":"Liu T, Gao P, Bu D, Liu D. Association between Toxoplasma Gondii infection and psychiatric disorders: a cross-sectional study in China. Sci Rep. 2022;12(1):15092. https:\/\/doi.org\/10.1038\/s41598-022-16420-y.","journal-title":"Sci Rep"},{"key":"10405_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3923\/jms.2013.215.220","volume":"13","author":"S Khademvatan","year":"2013","unstructured":"Khademvatan S, Khajeddin N, Izadi S, Saki J. Study of Toxoplasma Gondii infection in patients with bipolar disorder. J Med Sci. 2013;13:215\u201320.","journal-title":"J Med Sci"},{"issue":"1","key":"10405_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pnpbp.2011.09.003","volume":"36","author":"SI Gerber","year":"2012","unstructured":"Gerber SI, Krienke UJ, Biedermann N-C, Grunze H, Yolken RH, Dittmann S, Langosch JM. Impaired functioning in euthymic patients with bipolar disorder-HSV-1 as a predictor. Prog Neuro-Psychopharmacology Biol Psychiatry. 2012;36(1):110\u20136. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.09.003.","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"issue":"3","key":"10405_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bdi.12244","volume":"17","author":"O Stich","year":"2015","unstructured":"Stich O, Andres TA, Gross CM, Gerber SI, Rauer S, Langosch JM. An observational study of inflammation in the central nervous system in patients with bipolar disorder. Bipolar Disord. 2015;17(3):291\u2013302. https:\/\/doi.org\/10.1111\/bdi.12244.","journal-title":"Bipolar Disord"},{"key":"10405_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-6-178","volume":"6","author":"C Alvarado-Esquivel","year":"2006","unstructured":"Alvarado-Esquivel C, Alanis-Quinones O-P, Arreola-Valenzuela M-A, Rodr\u00edguez-Briones A, Piedra-Nevarez L-J, Duran-Morales E, Estrada-Martinez S, Mart\u00ednez-Garc\u00eda S-A, Liesenfeld O. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis. 2006;6:1\u20137. https:\/\/doi.org\/10.1186\/1471-2334-6-178.","journal-title":"BMC Infect Dis"},{"key":"10405_CR52","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fpsyt.2019.00766","volume":"10","author":"C Alvarado-Esquivel","year":"2019","unstructured":"Alvarado-Esquivel C, Estrada-Mart\u00ednez S, P\u00e9rez-Alamos AR. A case\u2013control seroprevalence study on the association between Toxoplasma Gondii infection and bipolar disorder. Front Psychiatry. 2019;10:766. https:\/\/doi.org\/10.3389\/fpsyt.2019.00766.","journal-title":"Front Psychiatry"},{"issue":"4","key":"10405_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4274\/tpd.galenos.2021.68077","volume":"45","author":"MC Sirin","year":"2021","unstructured":"Sirin MC, Kilic F, Demirdas A, Aridogan B, Cetin ES. An investigation into the Association between Toxoplasma Gondii Infection and bipolar disorder. Turkish J Parasitol. 2021;45(4):241\u20137. https:\/\/doi.org\/10.4274\/tpd.galenos.2021.68077.","journal-title":"Turkish J Parasitol"},{"issue":"3","key":"10405_CR54","first-page":"173","volume":"11","author":"R Najafi-Vosough","year":"2016","unstructured":"Najafi-Vosough R, Ghaleiha A, Faradmal J, Mahjub H. Recurrence in patients with bipolar disorder and its risk factors. Iran J Psychiatry. 2016;11(3):173.","journal-title":"Iran J Psychiatry"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10405-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T03:02:34Z","timestamp":1735786954000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10405"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10405-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from Birjand University of Medical Sciences, under the ethical code number IR.BUMS.REC.1399.385. All participants in our study provided informed consent prior to their inclusion. We adhered to all relevant guidelines and regulations throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}